5α-还原酶抑制剂用于前列腺癌化学预防 - Suppr

Suppr

超能文献

Prostate cancer chemoprevention with 5α-reductase inhibitors.

作者信息

Nepple Kenneth G, Andriole Gerald L

出版信息

Urol Oncol. 2012 Sep;30(5):553-4. doi: 10.1016/j.urolonc.2011.02.006.

DOI:10.1016/j.urolonc.2011.02.006

PMID:23193568

Abstract

摘要

相似文献

Prostate cancer chemoprevention with 5α-reductase inhibitors.

Urol Oncol. 2012 Sep;30(5):553-4. doi: 10.1016/j.urolonc.2011.02.006.

Chemoprevention using dutasteride: the REDUCE trial.

Curr Opin Urol. 2005 Jan;15(1):29-32. doi: 10.1097/00042307-200501000-00007.

Evolving role of 5-alpha reductase inhibitors in chemoprevention.

Nat Rev Clin Oncol. 2010 Sep;7(9):487-8. doi: 10.1038/nrclinonc.2010.114.

Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory?

J Gen Intern Med. 2011 Jul;26(7):798-801. doi: 10.1007/s11606-010-1622-4. Epub 2011 Jan 11.

Role of 5α-reductase inhibitors in prostate cancer prevention and treatment.

Urology. 2012 Jun;79(6):1197-205. doi: 10.1016/j.urology.2012.01.024. Epub 2012 Mar 23.

Dutasteride and prostate cancer.

N Engl J Med. 2010 Aug 19;363(8):794; author reply 794-6. doi: 10.1056/NEJMc1005498.

[Chemoprevention of prostate cancer].

Urologe A. 2004 May;43(5):557-61. doi: 10.1007/s00120-004-0537-2.

5-α reductase inhibitors and prostate cancer prevention: where do we turn now?

BMC Med. 2011 Sep 15;9:105. doi: 10.1186/1741-7015-9-105.

[Dutasteride provides chemoprevention].

Aktuelle Urol. 2006 Sep;37(5 Suppl):18.

A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.

Asian J Androl. 2011 Nov;13(6):812-8. doi: 10.1038/aja.2011.86. Epub 2011 Sep 5.

引用本文的文献

Adverse effects of common medications on male fertility.

Nat Rev Urol. 2015 Jul;12(7):401-13. doi: 10.1038/nrurol.2015.145. Epub 2015 Jun 23.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Prostate cancer chemoprevention with 5α-reductase inhibitors.

Urol Oncol. 2012 Sep;30(5):553-4. doi: 10.1016/j.urolonc.2011.02.006.

Chemoprevention using dutasteride: the REDUCE trial.

Curr Opin Urol. 2005 Jan;15(1):29-32. doi: 10.1097/00042307-200501000-00007.

Evolving role of 5-alpha reductase inhibitors in chemoprevention.

Nat Rev Clin Oncol. 2010 Sep;7(9):487-8. doi: 10.1038/nrclinonc.2010.114.

Battling prostate cancer with 5-alpha-reductase inhibitors: a pyrrhic victory?

J Gen Intern Med. 2011 Jul;26(7):798-801. doi: 10.1007/s11606-010-1622-4. Epub 2011 Jan 11.

Role of 5α-reductase inhibitors in prostate cancer prevention and treatment.

Urology. 2012 Jun;79(6):1197-205. doi: 10.1016/j.urology.2012.01.024. Epub 2012 Mar 23.

Dutasteride and prostate cancer.

N Engl J Med. 2010 Aug 19;363(8):794; author reply 794-6. doi: 10.1056/NEJMc1005498.

[Chemoprevention of prostate cancer].

Urologe A. 2004 May;43(5):557-61. doi: 10.1007/s00120-004-0537-2.

5-α reductase inhibitors and prostate cancer prevention: where do we turn now?

BMC Med. 2011 Sep 15;9:105. doi: 10.1186/1741-7015-9-105.

[Dutasteride provides chemoprevention].

Aktuelle Urol. 2006 Sep;37(5 Suppl):18.

A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.

Asian J Androl. 2011 Nov;13(6):812-8. doi: 10.1038/aja.2011.86. Epub 2011 Sep 5.

引用本文的文献

Adverse effects of common medications on male fertility.

Nat Rev Urol. 2015 Jul;12(7):401-13. doi: 10.1038/nrurol.2015.145. Epub 2015 Jun 23.